Real-time enrollment status for this advanced cancer clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 8:47 AM UTC
| NCT Number | NCT04969315 |
| Recruiting Status | Recruiting |
| Condition | Advanced Cancer |
| Phase | PHASE1 |
| Target Enrollment | 35 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Portage Biotech |
| Last Updated on CT.gov | September 15, 2026 (Sep 15, 2026) |
As of October 18, 2026: Clinical trial NCT04969315 is currently recruiting participants. This phase1 study for advanced cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by Portage Biotech. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04969315 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04969315 was last updated Sep 15, 2026 (September 15, 2026). HelloStudys verifies this status automatically.